COL1A1 and systemic sclerosis: Therefore, based on our results, the high expression of ENST00000313807, NON-HSAT194388.1, and COL1A1, as well as the low expression of hsa-miR-29a-3p, in SSc plasma cirexos may lead to a lower lymphocyte count in SSc serum and further promote the vascular abnormalities and fibrosis in SSc.